^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SGN-15

i
Other names: SGN-15, BMS-182248, cBR96-Dox
News
Trials
Company:
Pfizer
Drug class:
Topoisomerase II inhibitor, Lewis Y-related antigen-targeted antibody-drug conjugate
Related drugs:
News
Trials